Skip to content

Molecular Processes of the Relaxation Response in Older Adults

Molecular Processes of the Relaxation Response in Older Adults

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00179569
Enrollment
40
Registered
2005-09-16
Start date
2005-08-31
Completion date
2007-09-30
Last updated
2007-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Brief summary

The purpose of this study is to examine the molecular (nitric oxide) and biochemical (epinephrine, norepinephrine, cortisol and ACTH) parameters that are associated with RR elicitation and which may counteract the effects of acute stress in the elderly.

Interventions

8 weeks of relaxation response training

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 60-80 years of age * healthy individuals * willing and able to attend treatment sessions * willing to learn how to do and practice the relaxation-response * access to a working telephone * read and write English

Exclusion criteria

* Major medical or psychiatric illness * asthma or seasonal allergies (resulting in nitric oxide levels \>60 ppb) * smoking * previous relaxation-response practice * current use of the following medications:systemic corticosteroids, anti-convulsants/psychotics, immunosuppressants, cytotoxic therapy, anabolic steroids, antidepressants (other than SSRIs), dicyclomine, bile acid binding resins, or sympathomimetic medication

Design outcomes

Primary

MeasureTime frame
A primary goal of this study is to quantify the magnitude of relaxation response elicitation by comparing oxygen consumption during rest versus during elicitation of the relaxation response in a sample of healthy older adults.8 weeks

Secondary

MeasureTime frame
A second area of interest is the relationship between exhaled levels of nitric oxide (NO) and oxygen consumption (VO2) during relaxation response elicitation.8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026